EUVIMEDEUVIMED entdecken
Validierungsstudie

SEVMALrisk: an externally validated clinical risk score for early risk stratification of severe imported malaria

Perry J J van Genderen iD, Michele Fumarola, Robert-Jan Hassing, Foekje Stelma, Jaap J van Hellemond iD

Journal of Travel Medicine · 30.10.2026 · 33 (7)

DOI: 10.1093/jtm/taag080 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Travel Medicine, online erschienen am 02.09.2026. Verfasst von Perry J J van Genderen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Expertise Centre Travel-Risk Management, Corporate Travel Clinic, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Malaria, Communicable Diseases, Imported. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Early recognition of severe imported malaria is essential because treatment decisions frequently need to be made before reliable parasite density measurements become available. Objective tools to support early risk stratification during this interval are lacking. This study developed and externally validated SEVMALrisk, an explainable clinical risk score derived from a machine learning (ML) prediction model using routinely available admission laboratory parameters.

Methods

Adult patients with confirmed malaria from the Rotterdam Malaria Cohort (n = 832) were used for prediction model development. Eight supervised ML algorithms were compared. The best-performing model was optimized, interpreted using SHapley Additive exPlanations (SHAP) and translated into the SEVMALrisk clinical risk score. Independent external validation was performed in a multicentre cohort (n = 124).

Results

Random Forest showed the highest discriminative performance and was selected for model development. The optimized prediction model achieved an area under the receiver operating characteristic curve of 0.962 with good calibration (Brier score 0.048). SHAP analysis identified eight routinely available laboratory parameters (total bilirubin, aspartate aminotransferase (ASAT), leukocytes, thrombocytes, erythrocytes, creatinine, C-reactive protein and urea) for inclusion in the clinical risk score. The predefined decision threshold (26 points) remained unchanged during external validation. Internal validation yielded likelihood ratios of 9.39 (LR+) and 0.19 (LR−), corresponding to post-test probabilities of 51.9% and 2.1%, respectively. External validation demonstrated comparable performance (LR+ 8.02; LR− 0.18), with post-test probabilities of 59.2% and 3.2%.

Conclusion

SEVMALrisk is an explainable and externally validated clinical risk score for early risk stratification of severe imported malaria. Rather than replacing parasite density assessment or WHO severity criteria, it supports evidence-based treatment decisions before reliable parasite quantification becomes available.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MalariaCommunicable Diseases, ImportedHumansFemaleRisk AssessmentMaleAdultMiddle AgedNetherlandsPrediction AlgorithmsMachine LearningROC CurveSeverity of Illness IndexRisk Factors

Stichwörter der Autor:innen

clinical decision supportexplainable artificial intelligenceexternal validationimported malariamachine learningrisk assessmentsevere malaria

Autor:innen und Institutionen

  • Expertise Centre Travel-Risk Management, Corporate Travel Clinic, Rotterdam, The Netherlands.
  • Applied Responsible Artificial Intelligence Group, Centre of Expertise Perspective in Health, Avans Hogeschool, Breda, The Netherlands.
  • Department of Internal Medicine, Rijnstate Hospital, Arnhem, The Netherlands.
  • Eurofins PAMM, Veldhoven, The Netherlands.
  • Department of Microbiology and Infectious Diseases, Erasmus MC University Hospital, Rotterdam, The Netherlands.

ORCID-Profile: Perry J J van Genderen, Jaap J van Hellemond

Zitieren

APA

van Genderen, P. J. J., Fumarola, M., Hassing, R. J., Stelma, F., & van Hellemond, J. J. (2026). SEVMALrisk: an externally validated clinical risk score for early risk stratification of severe imported malaria. Journal of Travel Medicine, 33(7). https://doi.org/10.1093/jtm/taag080

Vancouver

van Genderen PJJ, Fumarola M, Hassing RJ, Stelma F, van Hellemond JJ. SEVMALrisk: an externally validated clinical risk score for early risk stratification of severe imported malaria. Journal of Travel Medicine. 2026;33(7). doi:10.1093/jtm/taag080

BibTeX
@article{vanGenderen2026,
  author = {van Genderen, Perry J J and Fumarola, Michele and Hassing, Robert-Jan and Stelma, Foekje and van Hellemond, Jaap J},
  title = {SEVMALrisk: an externally validated clinical risk score for early risk stratification of severe imported malaria},
  journal = {Journal of Travel Medicine},
  year = {2026},
  volume = {33},
  number = {7},
  doi = {10.1093/jtm/taag080}
}
Kostenlos starten →